A new flavonoid derivative, dosmalfate, attenuates the development of dextran sulphate sodium-induced colitis in mice

International Immunopharmacology

Volumn 3, Issue 13-14, 2003, Pages 1731-1741

  Villegas, Isabel ^a   De La Lastra, Catalina Alarcón ^a   Orjales, Aurelio ^b   La Casa, Carmen ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b Faes Farma SA   (Spain)

Author keywords

Dextran sulphate sodium; Dosmalfate; Ulcerative colitis

Indexed keywords

DEXTRAN SULFATE; DOSMALFATE; DRINKING WATER; FLAVANOID; INTERLEUKIN 1BETA; MYELOPEROXIDASE; PROSTAGLANDIN D2; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON MUCOSA; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; EVALUATION; FECES ANALYSIS; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECTUM HEMORRHAGE; WEIGHT REDUCTION;

EID: 0242459855     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2003.07.002     Document Type: Article

References (43)

1. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 115:1998;182-205.
2. Rogler G., Andus T. Cytokines in inflammatory bowel disease. World J. Surg. 22(4):1998;382-389.
3. Nitta M., Hirata I., Toshina K., et al. Expression of the EP4 prostaglandin E2 receptor subtype with rat dextran sodium sulphate colitis: colitis suppression by a selective against, ONO-AE1-329. Scand. J. Immunol. 56:2002;66-75.
4. Simmonds N.J., Rampton D.S. Inflammatory bowel disease: a radical view. Gut. 34:1994;861-865.
5. Veljaca M., Lesch C.A., Pllana R., et al. BPC-15 reduces trinitrobenzene sulphonic acid-induced colonic damage in rats. J. Pharmacol. Exp. Ther. 272:1995;417-422.
6. Rachmilewitz D., Simon P.L., Schwartz L.W., et al. Inflammatory mediators of experimental colitis in rats. Gastroenterology. 97(2):1989;326-337.
7. Fedorak R.N., Empey L.R., MacArthur C., et al. Misoprostol provides a colonic mucosal protective effect during acetic acid-induced colitis in rats. Gastroenterology. 98:1990;615-625.
8. Zhong W.W., Burke P.A., Drotar M.E., et al. Effects of prostaglandin E2, cholera toxin and 8-bromo-cyclic AMP on lipopolysaccaride-induced gene expression of cytokines in human macrophages. Immunology. 84:1995;446-452.
9. Cohn S.M., Schloemann S., Tessner T., et al. Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. J. Clin. Invest. 99:1997;1367-1379.
10. Ajuebor M.N., Singh A., Wallace J.L. Cyclooxygenase-2-derived prostaglandin D2 is an early anti-inflammatory signal in experimental colitis. Am. J. Physiol. 279:2000;G238-G244.
11. Hollman P.C.H., Arts I.C.W. Flavonols, flavones and flavanols - nature, occurrence and dietary burden. J. Sci. Food Agric. 80:2000;1081-1093.
12. Rice-Evans C.A., Miller N.J. Antioxidant activities of flavonoids as bioactive components of food. Biochem. Soc. Trans. 24(3):1996;790-795.
13. Youdim K.A., McDonald J., Kalt W., et al. Potential role of dietary flavonoids in reducing microvascular endothelium vulnerability to oxidative and inflammatory insults (small star, filled). J. Nutr. Biochem. 13:2002;282-288.
14. Setchell K.D., Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J. Nutr. 129(3):1999;758S-767S.
15. Cassidy A., Hanley B., Lamuela-Raventos R.M. Isoflavones, lignans and stilbenes - origins, metabolism and potential importance to human health. J. Sci. Food Agric. 80:2000;1044-1062.
16. Le-Marchand L. Cancer preventive effects of flavonoids - a review. Biomed. Pharmacother. 56:2002;296-301.
17. Hong T., Jin G.B., Cho S., et al. Evaluation of the anti-inflammatory effect of baicalein on dextran sulfate sodium-induced colitis in mice. Planta Med. 68(3):2002;268-271.
18. Sánchez de Medina F., Vera B., Gálvez J., et al. Effect of quercitrin on the early stages of hapten induced colonic inflammation in the rat. Life Sci. 70:2002;3097-3108.
19. Manuel Y., Keenoy B., Vertommen J., et al. The effect of flavonoid treatment on the glycation and antioxidant status in Type 1 diabetic patients. Diabet. Nutr. Metab. 12(4):1999;256-263.
20. Smith P.D. Neutrophil activation and mediators of inflammation in chronic venous insufficiency. J. Vasc. Res. 36(Suppl. 1):1999;24-36.
21. Hitzenberger G. Therapeutic effectiveness of flavonoids illustrated by daflon 500 mg. Wien. Med. Wochenschr. 147(18):1997;409-412.
22. Yang M., Tanaka T., Hirose Y., et al. Chemopreventive effects of diosmin and hesperidin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary-bladder carcinogenesis in male ICR mice. Int. J. Cancer. 73(5):1997;719-724.
23. Tanaka T., Makita H., Kawabata K., et al. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis. 18(5):1997;957-965.
24. Corcóstegui R., Labeaga L., Arteche J.K., et al. Gastroprotective action of Dosmalfate. Drugs Today. 36(Suppl. A):2000;25-39.
25. Villegas I., La Casa C., Orjales A., et al. Effects of dosmalfate, a new cytoprotective agent, on acute and chronic trinitrobenzene sulphonic acid-induced colitis in rats. Eur. J. Pharmacol. 460:2003;209-218.
26. Okayasu I., Hatakeyama S., Yamada M., et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 98:1990;694-702.
27. Gaudio E., Taddei G., Vetuschi A., et al. Dextran sulfate sodium (DSS) colitis in rats: clinical, structural and ultrastructural aspects. Dig. Dis. Sci. 44(7):1999;1458-1475.
28. Cooper H.S., Murthy S.N., Shah R.S., et al. Clinicopathologic study of dextran sulphate sodium experimental murine colitis. Lab. Invest. 69:1993;238-249.
29. Hartmann G., Bidlingmaier C., Siegmund B., et al. Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in mice. J. Pharmacol. Exp. Ther. 292:2000;22-30.
30. Grisham M.B., Beniot J.N., Granger D.N. Assessment of leukocyte involvement during ischemia and reperfusion on the intestine. Packer L., Glazer A.E. Methods in enzymology. Oxygen radicals in biological systems. 1990;729-741 Academic Press, San Diego.
31. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantise of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
32. Tessner T.G., Cohn S.M., Schloemann S., et al. Prostaglandins prevent decreased epithelial cell proliferation associated with dextran sulphate injury in mice. Gastroenterology. 115(4):1998;874-882.
33. Alarcón dela Lastra C., Martín M.J., Motilva V. Antiulcer and gastroprotective effect of quercetin: a gross and histologic study. Pharmacology. 48:1994;56-62.
34. Torres M.I., García-Martín M., Fernández M.I., et al. Experimental colitis induced by trinitrobenzenesulphonic acid. An ultrastructural and histochemical study. Dig. Dis. Sci. 44:1999;2523-2529.
35. Guo X., Wang W.P., Ko J.K., et al. Involvement of neutrophils and free radicals in the potentiating effects of passive cigarette smoking on inflammatory bowel disease in rats. Gastroenterology. 117:1999;884-892.
36. Sasaki S., Hirata I., Maemura K., et al. Prostaglandin E2 inhibits lesion formation in dextran sodium sulphate-induced colitis in rats and reduces the levels of mucosal inflammatory cytokines. Scand. J. Immunol. 51(1):2000;23-28.
37. Bito T., Roy S., Sen C.K., et al. Flavonoids differentially regulate IFNgamma-induced ICAM-1 expression in human keratinocytes: molecular mechanisms of action. FEBS Lett. 520:2002;145-152.
38. Friesenecker B., Tsai A.G., Allegra C., et al. Oral administration of purified micronized flavonoid fraction suppresses leukocyte adhesion in ischemia-reperfusion injury: in vivo observations in the hamster skin fold. Int. J. Microcirc. Clin. Exp. 14(1-2):1994;50-55.
39. Sartor R.B. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology. 106:1994;533-539.
40. Egger B., Bajaj-Elliott M., MacDonald T.T., et al. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion. 62:2000;240-248.
41. Reuter B.K., Asfaha S., Buret A., et al. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J. Clin. Invest. 98:1996;2076-2085.
42. Kabashima K., Saji T., Murata T., et al. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J. Clin. Invest. 109(7):2002;883-893.
43. Gilroy D.W., Colville-Nash P.R., Willis D., et al. Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 5(6):1999;698-701.